The significant role of epithelial cells in the pathogenesis of asthma and the importance of the interaction between CCL26 and the T2 cytokines IL-4 and IL-13 and their receptors in the inflammatory response suggest that the modulation of CCL26 production may provide a novel therapeutic opportunity for reducing airway inflammation in asthma. The gene discussed is IL13; the disease is asthma.